Ipratropium bromide HFA inhalation aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
From the U.S. FDA-approved label for Ipratropium bromide. Full label: DailyMed.
Ipratropium bromide HFA inhalation aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
From the U.S. FDA-approved label for Ipratropium bromide. Full label: DailyMed.
The usual starting dose of ipratropium bromide HFA inhalation aerosol is two inhalations four times a day. Ipratropium bromide HFA inhalation aerosol is a solution aerosol that does not require shaking. However, as with any other metered-dose inhaler, some coordination is required between actuating the canister and inhaling the medication.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Ipratropium bromide HFA inhalation aerosol is contraindicated in the following conditions., Hypersensitivity to ipratropium bromide or other ipratropium bromide HFA inhalation aerosol components, Hypersensitivity to atropine or any of its derivatives, Hypersensitivity to ipratropium bromide or other ipratropium bromide HFA inhalation aerosol components, Hypersensitivity to atropine or any of its derivatives
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Not indicated for the initial treatment of acute episodes of bronchospasm where rescue therapy is required for rapid response, Hypersensitivity reactions including anaphylaxis: Discontinue ipratropium bromide HFA inhalation aerosol at once and consider alternative treatments, Paradoxical bronchospasm: Discontinue ipratropium bromide HFA inhalation aerosol and consider other treatments if paradoxical bronchospasm occurs, Ocular effects: Use with caution in patients with narrow-angle glaucoma and instruct patients to consult a physician immediately if signs or symptoms of narrow-angle glaucoma develop…
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are described, or described in greater detail, in other sections: Hypersensitivity Reactions, Including Anaphylaxis, Paradoxical Bronchospasm, Ocular Effects, Urinary Retention Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
14 products from 5 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Ipravent (500mcg Respirator Solution | Ipratropium Bromide ((500mcg) | Cipla Ltd. | |
| Ipravent 15ml Respirator | Ipratropium Bromide (15ml) | Cipla Ltd. | |
| IPRAVENT 200 40mcg Inhaler | Ipratropium Bromide (40mcg) | Cipla Ltd. | |
| Ipravent 20mcg Inhaler | Ipratropium Bromide (20mcg) | Cipla Ltd. | |
| Ipravent 250mcg Respirator | Ipratropium Bromide (250mcg) | Cipla Ltd. | |
| Ipravent 40mcg Capsule | Ipratropium Bromide (40mcg) | Cipla Ltd. | |
| Aprovent Inhaler | Ipratropium (NA) | Cipla Ltd | packet of 1 Inhaler |
| Ipneb Solution for inhalation | Ipratropium (250mcg) | Lupin Ltd | bottle of 15 ml Solution for inhalation |
| Ipramist 250mcg Inhaler | Ipratropium (250mcg) | Zydus Cadila | packet of 200 MDI Inhaler |
| Ipramist 250mcg Solution for inhalation | Ipratropium (250mcg) | Zydus Cadila | bottle of 15 ml Solution for inhalation |
| Ipratop 200mcg Inhaler | Ipratropium (200mcg) | AstraZeneca | packet of 1 Inhaler |
| Ipravent Respirator Solution | Ipratropium (250mcg) | Cipla Ltd | bottle of 15 ml Respules |
| Ipravent Respules 2ml | Ipratropium (500mcg) | Cipla Ltd | strip of 5 respules |
| Ipravent Rotacaps | Ipratropium (40mcg) | Cipla Ltd | packet of 30 capsules |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage Store at 20°C to 25°C (68°F to 77°F); Keep out of reach of children.
Storage information from the U.S. FDA-approved label.
Ipratropium bromide is recorded in the NepalDoc medicine catalog for: Asthma, chronic obstructive pulmonary disease, chronic bronchitis, emphysema.
For Asthma: Bambuterol hydrochloride, Beclomethasone dipropionate, Theophylline, Theophylline + Etophylline.
For emphysema: Salbutamol + Bromhexine.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
